Mandate

Vinge advised Sapa on Chinese railways agreement

April 28, 2011

Vinge in Hong Kong has advised Sapa (a wholly owned subsidiary of the Norwegian Orkla ASA) in conjunction with the entry into an agreement with China's largest aluminum company, Chalco, concerning the supply of aluminum profiles to the Chinese railway industry. The joint venture agreement was executed in April this year at a cermony in Beijing attended by 70 specially invited guests. Each party holds 50% of the shares in the joint venture company. In total, the deal relates to an investment of approximately EUR 70 million. The joint venture agreement entails, among other things, that Sapa will be involved in the development of high speed trains for the Chinese market. The agreement has attracted a great deal of interest in both China and Norway.

Vinge's team consisted of Katarina Nilsson, the head of Vinge's China operations.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026